WebJan 11, 2024 · ROCKVILLE, MD and SHENZHEN, CHINA - (NewMediaWire) - January 11, 2024 - (ACN Newswire) - HighTide Therapeutics Inc. ("HighTide"), a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive diseases, today announced the dosing of the first patient in a Phase 2b … Web君圣泰医药（HighTide Therapeutics Inc.）是一家全球一体化的新型生物技术公司，专注代谢性疾病、消化系统疾病等领域的重大未满足临床需求。公司已构建丰富产品管线，在全球推进多项中、后期临床试验，开发2型糖尿病（T2DM）、非酒精性脂肪性肝炎（NASH）、严重高甘油三酯血症（SHTG）、原发性硬化 ...

HighTide Therapeutics LinkedIn

WebOct 10, 2024 · HighTide Therapeutics Inc., founded in 2011 in Shenzhen, China, is dedicated to the discovery and development of innovative therapeutics for people suffering from non-viral chronic liver diseases, gastrointestinal diseases and metabolic disorders with large and unsatisfied market needs. HTD1801, HighTide's lead program, is a new molecular ... WebDec 15, 2024 · HighTide is a globally integrated clinical-stage biopharmaceutical company focusing on the discovery and development of innovative multifunctional therapies for metabolic and digestive diseases... diseases of the hypothalamus gland

HighTide Therapeutics and Quotient Sciences Announce …

WebHighTide Therapeutics has raised a $107 million Series C round to fund mid-stage studies in metabolic and digestive diseases, with the goal of filing for approval in China within two to three years. HighTide, which has roots in Shenzhen, China, and Maryland, disclosed the round Thursday morning in advance of the JPMorgan healthcare meeting. ... WebFeb 1, 2024 · HighTide Therapeutics Inc. is dedicated to the development of innovative therapeutics for people suffering from non-viral chronic liver diseases, gastrointestinal diseases and metabolic... WebJan 6, 2024 · HighTide Therapeutics is a global clinical-stage biopharmaceutical company focused on discovering and developing novel drugs to treat chronic liver diseases, gastrointestinal diseases and... diseases of silkworm slideshare ppt